Moy Jamie K, Szabo-Pardi Thomas, Tillu Dipti V, Megat Salim, Pradhan Grishma, Kume Moeno, Asiedu Marina N, Burton Michael D, Dussor Gregory, Price Theodore J
School of Behavioral and Brain Sciences, University of Texas at Dallas, Richardson, TX 75080, United States.
Department of Medical Pharmacology, University of Arizona, Tucson, AZ, 85724, United States.
Neurobiol Pain. 2018 Oct 19;5:100024. doi: 10.1016/j.ynpai.2018.10.001. eCollection 2019 Jan-Jul.
Brain-derived neurotrophic factor (BDNF) signaling through its cognate receptor, TrkB, is a well-known promoter of synaptic plasticity at nociceptive synapses in the dorsal horn of the spinal cord. Existing evidence suggests that BDNF/TrkB signaling in neuropathic pain is sex dependent. We tested the hypothesis that the effects of BDNF/TrkB signaling in hyperalgesic priming might also be sexually dimorphic. Using the incision postsurgical pain model in male mice, we show that BDNF sequestration with TrkB-Fc administered at the time of surgery blocks the initiation and maintenance of hyperalgesic priming. However, when BDNF signaling was blocked prior to the precipitation of hyperalgesic priming with prostaglandin E (PGE), priming was not reversed. This result is in contrast to our findings in male mice with interleukin-6 (IL6) as the priming stimulus where TrkB-Fc was effective in reversing the maintenance of hyperalgesic priming. Furthermore, in IL6-induced hyperalgesic priming, the BDNF sequestering agent, TrkB-fc, was effective in reversing the maintenance of hyperalgesic priming in male mice; however, when this experiment was conducted in female mice, we did not observe any effect of TrkB-fc. This markedly sexual dimorphic effect in mice is consistent with recent studies showing a similar effect in neuropathic pain models. We tested whether the sexual dimorphic role for BDNF was consistent across species. Importantly, we find that this sexual dimorphism does not occur in rats where TrkB-fc reverses hyperalgesic priming fully in both sexes. Finally, to determine the source of BDNF in hyperalgesic priming in mice, we used transgenic mice ( × mice) with BDNF eliminated from microglia. From these experiments we conclude that BDNF from microglia does not contribute to hyperalgesic priming and that the key source of BDNF for hyperalgesic priming is likely nociceptors in the dorsal root ganglion. These experiments demonstrate the importance of testing mechanistic hypotheses in both sexes in multiple species to gain insight into complex biology underlying chronic pain.
脑源性神经营养因子(BDNF)通过其同源受体TrkB发出信号,是脊髓背角伤害性突触处突触可塑性的一个众所周知的促进因子。现有证据表明,神经性疼痛中的BDNF/TrkB信号传导存在性别依赖性。我们检验了这样一个假设,即BDNF/TrkB信号在痛觉过敏启动中的作用可能也存在性别差异。利用雄性小鼠的切口术后疼痛模型,我们发现,在手术时给予TrkB-Fc来隔离BDNF,可阻断痛觉过敏启动的起始和维持。然而,在用前列腺素E(PGE)引发痛觉过敏启动之前阻断BDNF信号时,启动并未逆转。这一结果与我们在以白细胞介素-6(IL6)作为启动刺激的雄性小鼠中的发现形成对比,在后者中TrkB-Fc可有效逆转痛觉过敏启动的维持。此外,在IL6诱导的痛觉过敏启动中,BDNF隔离剂TrkB-fc可有效逆转雄性小鼠痛觉过敏启动的维持;然而,当在雌性小鼠中进行该实验时,我们未观察到TrkB-fc有任何作用。小鼠中这种明显的性别差异效应与最近在神经性疼痛模型中显示的类似效应一致。我们检验了BDNF的性别差异作用在不同物种中是否一致。重要的是,我们发现大鼠中不存在这种性别差异,在大鼠中TrkB-fc可完全逆转两性的痛觉过敏启动。最后,为了确定小鼠痛觉过敏启动中BDNF的来源,我们使用了从小胶质细胞中消除了BDNF的转基因小鼠(×小鼠)。从这些实验中我们得出结论,小胶质细胞来源的BDNF对痛觉过敏启动没有作用,痛觉过敏启动中BDNF的关键来源可能是背根神经节中的伤害感受器。这些实验证明了在多个物种的两性中检验机制假设对于深入了解慢性疼痛背后复杂生物学的重要性。